2013 Prevention Guidelines

What's a Clinician to Do? Implementation of the 2013 Prevention Guidelines

Dr. Donald Lloyd-Jones, thought leader who played a major role in the development of the 2013 risk assessment and prevention guidelines, takes the learner through a case-based approach in the clinical application of the guidelines.

Credit: .92 (0.5 Pharmacology)
Cost: Free

Take this Course

Faculty
  •  Donald Lloyd-Jones, MD/ScM
Upon completion, participants will be able to:
  • Describe process for assessing appropriateness for statin therapy in the high risk primary prevention patient
  • Describe steps in the addition of non-statin therapy to the treatment regimen of a patient with residual risk.
Lipid Profile Test
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602.